Andrew Wardley

8PUBLICATIONS
81CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 29, 2025
The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial.

Iseult M Browne, Javier Pascual, Rosalind J Cutts

|Dec 11, 2023
Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer.

Maria Coakley, Guillermo Villacampa, Prithika Sritharan

|Oct 06, 2023
Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study.

Nicholas C Turner, A Douglas Laird, Melinda L Telli

|Sep 29, 2023
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010).

Alistair Ring, Lucy S Kilburn, Alex Pearson

|Nov 13, 2020
Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current Literature.

Eirini Thanopoulou, Leila Khader, Morena Caira

|Sep 04, 2020
Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT.

Helena Earl, Louise Hiller, Anne-Laure Vallier

Pageof 2

Frequent Collaborators

4 joint publications

Nicolas C Turner

3 joint publications

Iain R Macpherson

3 joint publications

Judith M Bliss

3 joint publications

Lucy S Kilburn